ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,526.00
-3.50 (-0.23%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.50 -0.23% 1,526.00 1,527.50 1,528.00 1,538.50 1,512.00 1,519.50 5,861,235 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 12.77 62.91B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,529.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,820.00p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £62.91 billion. Gsk has a price to earnings ratio (PE ratio) of 12.77.

Gsk Share Discussion Threads

Showing 19551 to 19573 of 33350 messages
Chat Pages: Latest  794  793  792  791  790  789  788  787  786  785  784  783  Older
DateSubjectAuthorDiscuss
01/5/2019
15:50
If you have 40000 shares and you buy and sell some or all of them when the share price spikes either way then you could make a capital gains of £100,000,timing and luck will have to be your co-pilots .
abdullla
01/5/2019
14:58
Dividend will never be increased been the same for years, just like holding a bond not a ord share. The whole point holding shares is for dividend growth and capital gain. GSK shareprice the same has it was 25 years ago, what growth. Poor show.
montyhedge
01/5/2019
13:52
Just cannot seem to sort earning cash, earnings per share poor, always the same, hover around this until ex div then back to 15.20, time to buy in and sell again on way to next ex div, good trading share but thats all, useless for capital growth and if you want income there are funds with higher yields and lower stock specific risks, if she decides to buy another bio tech for billions this will tank again and put div at risk, its still being paid from debt. I know you " lifers " are waiting for the March to 1900 but its never gonna happen.
porsche1945
01/5/2019
13:35
Great figs imo! spud
spud
01/5/2019
13:28
Thanks TM,you are right,euphoria was at the open for most investors when the share price jumped 20p at the opening bell,now things are balancing out for a brighter future,imo
abdullla
01/5/2019
12:49
abdullla:

The reduction primarily reflected the adverse phasing of payments for returns and rebates, as well as the initial step-down impact from Advair generic competition and an increase in trade receivables as a result of strong sales in the quarter, partly offset by improved operating profits and lower contingent consideration payments compared with Q1 2018 which included a milestone payment to Novartis.

tradermichael
01/5/2019
12:39
There's those who are reading between the lines,abdullla just on the first paragraph hence the euphoria,sorry
abdullla
01/5/2019
12:35
Market thinking too. ;)
alphorn
01/5/2019
12:32
Make your mind up, abdulla.
keyno
01/5/2019
12:24
Maybe issues short term, but the longer term is looking good, which I think is an improving picture!
jadeticl3
01/5/2019
12:16
Looks trouble ahead on free cash flow
abdullla
01/5/2019
12:09
With these results she should be dishing out caviar.
abdullla
01/5/2019
08:52
Yes, but Emma will be serving tea and biscuits during the webcast at 14.00 BST
tradermichael
01/5/2019
08:51
They need to sort out their manufacturing problems !
gbh2
01/5/2019
08:36
Yes you better have the tea trolley ready when the masters wake up.
abdullla
01/5/2019
08:35
12.00 GMT last year :-)
sicker
01/5/2019
07:50
yes, but I think they wait until the US wakes up.
thamestrader
01/5/2019
07:49
Are results due out today?
jadeticl3
01/5/2019
07:05
2 weeks to next x-dividend …… ;0)
tradermichael
30/4/2019
21:10
TM - will they all be additional sales or will some of those new sales come from existing drugs (sales)?
alphorn
30/4/2019
21:07
Some of the world’s largest drugmakers painted an optimistic picture of the industry’s prospects this year, after posting better than expected first-quarter earnings thanks to growth in China and new cancer treatments.

Pfizer, Merck and Eli Lilly all increased their earnings forecasts for 2019 on Tuesday, even as investors continue to worry about the prospect of US regulation on drug prices and US presidential candidates pledge to transform the healthcare system.



Interesting comment vis earnings forecasts UP despite fear over US regulation on drug prices.....

crossing_the_rubicon
29/4/2019
18:23
Not sure what you mean?
tradermichael
29/4/2019
14:01
TM - will that be incremental sales or cannibalisation?
alphorn
Chat Pages: Latest  794  793  792  791  790  789  788  787  786  785  784  783  Older